Products for Research Use Only
RegisterLogin

TQH-2722

CAT: 0804-HY-P991515Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P991515Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
TQH-2722 is a humanized IgG4 anti-IL-4Rα monoclonal antibody. TQH-2722 targets the IL-4Rα receptor in humans, effectively disrupting the interaction between IL-4Rα and the downstream cytokines IL-4 and IL-13, thereby inhibiting inflammatory response. TQH-2722 can be used for the study of atopic dermatitis (AD) and chronic rhinosinusitis with nasal polyps (CRSwNP) [1].
UNSPSC
12352203
Target
Interleukin Related
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
References & Citations
[1]Li X, et al. Safety, pharmacokinetics and population pharmacokinetic model of TQH2722, a novel IL-4Rα monoclonal antibody in healthy subjects: a phase I, first-in-human, single-dose and multiple-dose escalation study. J Pharm Sci. 2025 Jul;114 (7) :103773.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported

Related Products

CatalogName
HY-155489-01DDO-2728
HY-123797-01KGA-2727
HY-117725S-2720
HY-106920Kynostatin 272
HY-101925-01CM-272
HY-100726-01GNE-272
HY-163901-01E6-272
HY-169052Cyy-272
HY-100726RGNE-272 (Standard)
HY-W952895CRBN ligand-272

Alternative Products

CatalogName
T9901A-1587-01TQH-2722

Popular Products